Rexahn Pharmaceuticals (RNN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RNN | AZN | AMGN | GILD | VRTX |
| Company | Rexahn Pharmaceuticals | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NYSE Arca | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 5.25 | 162.06 | 415.52 | 132.68 | 525.02 |
| High | 5.44 | 162.26 | 421.79 | 136.85 | 532.23 |
| Low | 4.97 | 158.61 | 412.20 | 132.01 | 522.01 |
| Last | 5.24 | 158.75 | 414.30 | 135.77 | 529.65 |
| Change | +0.01 | -3.16 | -2.90 | +2.71 | +5.74 |
| Percent Change | +0.19% | -1.95% | -0.70% | +2.04% | +1.10% |
| Volume | 34,400 | 2,754,800 | 2,029,700 | 5,493,600 | 1,065,400 |
| 20-Day Average Volume | 26,185 | 3,866,805 | 2,717,610 | 7,002,345 | 1,392,750 |
| Previous | 5.23 | 161.91 | 417.20 | 133.06 | 523.91 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.07 | 166.12 | 384.70 | 132.32 | 485.69 |
| 20-Day Raw Stochastic | 46.90% | 24.68% | 88.96% | 62.77% | 79.65% |
| 20-Day Relative Strength | 44.69 | 38.57 | 69.09 | 55.81 | 67.53 |
| Weighted Alpha | -55.70 | -8.86 | +44.35 | +13.45 | +37.47 |
| Today's Opinion | 88% Sell | 100% Sell | 100% Buy | 40% Buy | 100% Buy |
| Yesterday's Opinion | 88% Sell | 100% Sell | 100% Buy | 8% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 88% Sell | 72% Buy | 24% Sell | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.29% since 05/31/19 | +2.01% since 08/04/26 | +6.23% since 08/04/26 | +0.38% since 08/04/26 | +10.64% since 08/04/26 |
| Low | 4.93 on 06/03/19 | 158.61 on 08/11/26 | 391.00 on 08/05/26 | 129.02 on 08/06/26 | 479.02 on 08/05/26 |
| High | 5.66 on 06/05/19 | 164.45 on 08/05/26 | 421.79 on 08/11/26 | 137.80 on 08/05/26 | 546.17 on 08/10/26 |
| 1-Month | |||||
| %Chg | -11.04% since 05/07/19 | -7.49% since 07/10/26 | +14.01% since 07/10/26 | +4.58% since 07/10/26 | +9.12% since 07/10/26 |
| Low | 4.71 on 05/20/19 | 153.41 on 08/03/26 | 353.95 on 07/15/26 | 127.61 on 07/23/26 | 465.00 on 07/23/26 |
| High | 6.10 on 05/08/19 | 175.04 on 07/29/26 | 421.79 on 08/11/26 | 140.61 on 07/17/26 | 546.17 on 08/10/26 |
| 3-Month | |||||
| %Chg | -21.66% since 03/07/19 | -12.71% since 05/11/26 | +25.70% since 05/11/26 | +1.69% since 05/11/26 | +21.71% since 05/11/26 |
| Low | 4.71 on 05/20/19 | 153.41 on 08/03/26 | 320.96 on 05/19/26 | 121.39 on 06/10/26 | 420.01 on 06/03/26 |
| High | 9.18 on 04/16/19 | 196.41 on 07/02/26 | 421.79 on 08/11/26 | 140.61 on 07/17/26 | 546.17 on 08/10/26 |
| 6-Month | |||||
| %Chg | -60.30% since 12/07/18 | -22.47% since 02/11/26 | +13.02% since 02/11/26 | -12.86% since 02/11/26 | +14.83% since 02/11/26 |
| Low | 4.71 on 05/20/19 | 153.41 on 08/03/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 19.80 on 01/18/19 | 212.71 on 02/18/26 | 421.79 on 08/11/26 | 156.95 on 02/13/26 | 546.17 on 08/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 21,060 | 246,206,640 | 223,983,840 | 168,348,672 | 134,427,824 |
| Shares Outstanding, K | 4,019 | 1,550,908 | 540,632 | 1,239,955 | 253,805 |
| Annual Sales, $M | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income, $M | -14,370,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Qtr Sales, $M | 0 | 15,384,000,000 | 10,054,000,000 | 7,803,000,000 | 3,333,900,000 |
| Last Qtr Income, $M | -2,340,000 | 2,507,000,000 | 2,375,000,000 | -10,496,000,000 | 1,099,800,000 |
| 60-Month Beta | 0.81 | 0.26 | 0.41 | 0.32 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.63 on 07/27/26 | 6.29 on 08/04/26 | -6.75 on 08/04/26 | 4.73 on 08/03/26 |
| Latest Earnings Date | 08/05/19 | 11/05/26 | 11/03/26 | 10/29/26 | 11/02/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividend Date | N/A | 02/20/26 | 08/21/26 | 09/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.67 | 18.65 | 0.00 | 30.78 |